Rita Baldi, PhD

Rita
Baldi
PhD
Research Instructor
Psychiatry and Behavioral Sciences

Elizabeth Crofford, MSN, PMHNP

Elizabeth
Crofford
Professional Staff
Psychiatry and Behavioral Sciences
Division of General Psychiatry

Elizabeth Crofford works with Dr. Warren Taylor examining the factors that contribute to the occurrence, phenomenology, and outcomes of late-life depression. 

Elizabeth Crofford is a Nashville native. She received her Bachelor’s of Science in Nursing at Belmont University. She continued her education at University of Tennessee, Knoxville where she completed her Master’s of Science in Nursing specializing in Psychiatry. Elizabeth began her career working in community mental health in Nashville and then joined the Department of Psychiatry and Behavioral Sciences at Vanderbilt in 2021. Clinical care includes practice in the Vanderbilt Early Psychosis Program outpatient clinic and geriatric psychiatry outpatient clinic. 

Amanda Satterthwaite, MD

Amanda
Satterthwaite
MD
Assistant Professor
Psychiatry and Behavioral Sciences
Division of General Psychiatry

Dr. Satterthwaite joined the faculty in 2020. She received her bachelor's degree in Sociology and Spanish Literature from Princeton University, and her medical degree from Meharry Medical College. She completed dual residency training in Internal Medicine and Psychiatry at Tulane University School of Medicine in New Orleans, LA. Her professional interests include comprehensive medical and psychiatric care for patients with schizophrenia and severe mental illness, integrated care for patients with chronic medical comorbidities, and the treatment of coexisting acute medical and psychiatric complications. She is a proponent for eliminating healthcare disparities and increasing mental health awareness in minority communities as well as persons living in poverty.        

Jennifer Vega, PhD

Jennifer
Vega
PhD
Research Instructor
Psychiatry and Behavioral Sciences

Cancer-Related Cognitive Impairment, Subjective Cognitive Decline, Chemobrain, Populations at Risk for Dementia, Cognitive Aging, Clinical Trials, Non-Pharmaceutical Cognitive Interventions , Cognitive Remediation

Representative Publications

Vega JN & Newhouse PA. (2014). Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Current Psychiatry Reports, 16(10): 490. http://doi.org/10.1007/s11920-014-0490-8

Vega JN, Hohman TJ, Pryweller JR, Dykens EM & Thornton-Wells TA. (2015). Resting State Functional Connectivity in Individuals with Down Syndrome and Williams Syndrome Compared to Typically Developing Controls. Brain Connectivity, 5(8): 461-475. http://doi.org/10.1089/brain.2014.0266

Vega JN, Zurkovsky L, Albert K, Melo A, Boyd BD, Dumas J, Woodward N, McDonald BC, Saykin AJ, Park JH, Naylor M, Newhouse PA. (2016). Altered Brain Connectivity In Early Postmenopausal Women with Subjective Cognitive Impairment. Frontiers in Neuroscience, 10, 433. http://doi:10.3389/fnins.2016.00433

Vega JN, Dumas J, Newhouse PA. (2017). Cognitive Effects Cancer and Cancer-Related Treatments in Older Adults. American Journal of Geriatric Psychiatry, 25(12): 1415-1426. http://doi.org/10.1016/j.jagp.2017.04.001

Vega JN, Dumas J, Newhouse PA. (2018). Self-Reported Chemotherapy-Related Cognitive Impairment Compared with Cognitive Complaints following Menopause. Psycho-Oncology, 27: 2198–2205. http://doi.org/10.1002/pon.4796

Vega JN, Albert KM, Mayer IA, Taylor WD, Newhouse PA. (2019). Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study. Journal of Cancer Survivorship, J Cancer Surviv. 13(5): 673-686. http://doi.org/10.1007/s11764-019-00786-6

Vega JN, Albert KM, Gandelman J, Boyd B, Newhouse PA, Taylor WD. (2020). Persistent Intrinsic Functional Network Connectivity Alterations in Middle-Aged and Older Women with Remitted Depression. Front psychiatry (2020) 11:62. doi:10.3389/fpsyt.2020.00062

Vega JN, Albert KM, Mayer IA, Taylor WD, Newhouse PA. (2021). Subjective Cognition and Mood in Chemotherapy-Related Cognitive Impairment. Journal of Cancer Survivorship: Research and Practice. https://doi.org/10.1007/s11764-021-01055-1

jennifer.n.vega.1@vumc.org

Dr. Vega is a cognitive neuroscientist with an expertise in cancer survivorship. She received her doctorate in Neuroscience from Vanderbilt University in 2018. Her dissertation work focused on investigating nicotine as a treatment for cognitive impairment secondary to chemotherapy in lymphoma, breast, ovarian and colon cancer survivors. Dr. Vega's postdoctoral research has focused largely on developing and initiating a feasibility study looking at using a novel cognitive enhancement strategy to treat chemotherapy-related cognitive impairment in cancer survivors. Her scientific interests lie in translational research focused on pathologic cognitive aging in patient populations vulnerable to late-life cognitive impairment.

RSS: